삼성서울병원

Ko En

Pulmonary and Critical Care Medicine Chung, Man Pyo M.D

Expertise
interstitial lung disease, pulmonary fibrosis
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

1995 Ph.D. in Medicine Seoul National University, Korea
1990 Master of Science Seoul National University, Korea
1986 Seoul National University College of Medicine, Korea

Post-Graduate Training

Fellowship   1993~1994 Division of Pulmonology, Seoul National University Hospital, Korea
Residency   1987~1990 Department of Medicine, Seoul National University Hospital, Korea
Internship   1986~1987 Seoul National University Hospital, Korea

Professional Appointments

2007~Present Professor Department of Medicine, Sungkyunkwan University School of Medicine
1994~Present Staff Division of Pulmonary and critical care medicine, Samsung Medical Center
2009~2015 Chair Division of Pulmonary and critical care medicine, Samsung Medical Center
2001~2007 Associate Professor Department of Medicine, Sungkyunkwan University School of Medicine
2000~2002 Postdoctoral Research Fellow University of Iowa, USA
1997~2001 Assistant Professor Department of Medicine, Sungkyunkwan University School of Medicine

Professional Memberships

Member of Korean Society of Tuberculosis and Pulmonary Disease
Member of Korean Medical Association
Active member of American Thoracic Society
Active member of American College of Chest Physicians

Selected Publications

  • ANN AM THORAC SOC 2021 10.1513/AnnalsATS.202005-451OC Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmonary Fibrosis A Nationwide Cohort Study Moon1, SW; Kim, SY; Chung, MP; Yoo, H; Jeong, SH; Kim, DS; Song, JW; Lee, HL; Choi, SM; Kim, YW; Kim, YH; Park, CS; Park, SW; Park, JS; Jegal, Y; Lee, J; Uh, ST; Kim, TH; Lee, JH; Kim, YH; Shin, B; Lee, HK; Yang, SH; Lee, H; Kim, SH; Lee, EJ; Choi, HS; Shin, H; Park, YB; Shin, JW; Park, MS
    View PubMed
  • ADV THER 2020 10.1007/s12325-020-01328-8 Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients Chung1, MP; Park, MS; Oh, IJ; Lee, HB; Kim, YW; Park, JS; Uh, ST; Kim, YS; Jegal, Y; Song, JW
    View PubMed
  • Int J Chron Obstruct Pulmon Dis 2019 10.2147/COPD.S210759 Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy Kim1, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY
    View PubMed
  • BMC PULMONARY MEDICINE 2019 10.1186/s12890-019-0905-8 Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study Yoo1, H; Jeong, BH; Chung, MJ; Lee, KS; Kwon, OJ; Chung, MP
    View PubMed
  • INT J TUBERC LUNG D 2019 10.5588/ijtld.18.0194 Clinical features and prognosis of patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease Lee1, SH; Park, JS; Kim, SY; Kim, DS; Kim, YW; Chung, MP; Uh, ST; Park, CS; Park, SW; Jeong, SH; Park, YB; Lee, HL; Shin, JW; Lee, JH; Jegal, Y; Lee, HK; Kim, YH; Song, JW; Park, MS
    View PubMed